Pharmaceuticals

Eli Lilly (LLY) recently suspended a phase III study that was being conducted with its oncology candidate, tasisulam. The study has been put on “full clinical hold” due to safety concerns. Tasisulam was being evaluated for the second-line treatment of patients suffering from unresectable or...

The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared a 3.1 percent increase in the company's quarterly dividend, beginning in the first quarter of 2011. The dividend increase will result in a quarterly dividend of thirty-three cents ($0.33) per share on the $.10 par...

Eli Lilly (LLY) recently suspended a phase III study that was being conducted with its oncology candidate, tasisulam. The study has been put on “full clinical hold” due to safety concerns. Tasisulam was being evaluated for the second-line treatment of patients suffering from unresectable or...

Here's a list of events and conferences of interest for tomorrow, December 15. Celgene (NASDAQ: CELG), Dendreon (NASDAQ: DNDN) and ViroPharma Incorporated (NASDAQ: VPHM) are all scheduled to speak at the Deutsche Bank Securities Inc. BioFEST Conference. Eastman Chemical Company (NYSE: EMN) and...

Bob Doll of Blackrock is on CNBC and he is saying that America is still the best place to put your money, as fiscal policy is getting more accomodating to investment capital, and absent inflation it is a wonderful place to earn return on your investments. Doll recommended shares of Ford (NYSE: F...

Shares of San Diego, California-based pharmaceutical company Cypress Bioscience, Inc. (Nasdaq: CYPB) are trading up 19% at $5.70 per share during the Tuesday afternoon trading session. The company's stock surged after it was announced that it had rejected a $6 per share takeover bid from Ramius LLC...

By 12:58 pm, the Dow Jones Industrial Average was up 71.52 points, or 0.63%, to 11,500.08, while the broader Standard & Poor's 500 index had gained 5.01 points, or 0.40%. The NASDAQ composite index rose 9.54 points, or 0.36%. Some of the narrow based indexes supporting the markets are Cement...

Recently, Novartis AG (NVS) presented data from a phase II study of its drug Afinitor at the annual Antonio Breast Cancer Symposium. The study was testing Afinitor plus hormonal therapy tamoxifen in patients with advanced metastatic breast cancer who have been previously treated with an aromatase...

Helen of Troy Limited (NASDAQ: HELE) shares gained 2.92% to create a new 52-week high of $29.64. HELE announced its plans to purchase Kaz for about $260 million. Matrixx Initiatives Inc (NASDAQ: MTXX) shares jumped 56.25% to touch a new 52-week high of $8.00. MTXX agreed to be purchased by H.I.G....

Recently, Novartis AG (NVS) presented data from a phase II study of its drug Afinitor at the annual Antonio Breast Cancer Symposium. The study was testing Afinitor plus hormonal therapy tamoxifen in patients with advanced metastatic breast cancer who have been previously treated with an aromatase...

Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC, today announced that Cypress Bioscience, Inc. (Nasdaq: CYPB) has rejected its fully financed offer to acquire all of Cypress' outstanding Common Stock in a negotiated transaction for $6.00 per share in cash.